Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.02.020 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Rachel A Charlton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Bath, UK. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Arthritis, Rheumatoid, Delayed Diagnosis, Antirheumatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals Inc, King's College London, National Health Service Corps.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to compare time to diagnosis among patients with psoriatic arthritis (PsA) with that of patients with rheumatoid arthritis (RA) and compare initial treatment and outcomes. METHODS: Patients with PsA were identified from the National Early Inflammatory Arthritis Audit between May 2018 and October 31, 2019, and matched to patients with RA (1:1) on age and sex. Patient characteristics and time to diagnosis were compared between PsA and RA groups. Further comparisons were made, restricted to matched pairs of patients with polyarticular PsA, including disease activity, disease impact, and treatment initiation. RESULTS: In total, 2120 patients with PsA were matched to patients with RA, of which 1250 had polyarticular disease. Symptom duration before referral was longer in patients with PsA than that in patients with RA. Patients with PsA had a longer time from general practitioner (GP) presentation to diagnosis (mean, 112 v 89 days; hazard ratio [HR], 0.87; 95% CI, 0.79-0.96; P = .007), including a delay in diagnosis once referrals were received in secondary care (HR, 0.86; 95% CI, 0.80-0.95; P = .002). In patients with polyarticular disease, less disease-modifying antirheumatic drugs (DMARDs) were prescribed at baseline to patients with PsA compared with those to patients with RA (54.0% and 69.0%, respectively; P < .001). Patients with RA had a higher Disease Activity Score in 28 joints at baseline, but by 3 months, the average score was 0.27 (95% CI, 0.13-0.4) higher in patients with PsA. CONCLUSIONS: Compared with patients with RA, patients with PsA have a longer duration of symptoms before referral and a longer interval between presentation to the GP and receiving a diagnosis. Most people agreed a treat-to-target strategy but fewer DMARDs were commenced for patients with PsA than those for patients with RA and a lower improvement in disease activity was achieved at 3 months, suggesting undertreatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Bath, Bath, UK.
- Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK.
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
- Department of Inflammation Biology, King's College London, London, UK.
- Bath Institute for Rheumatic Disease, Bath, UK.
- Department of Life Sciences, University of Bath, Bath, UK; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK. Electronic address: w.tillett@nhs.net.
Förderung
- Janssen Pharmaceuticals Inc
- King's College London
- National Health Service Corps
- British Society for Rheumatology
Zitieren
APA
Charlton, R. A., Gates, E., Coates, L. C., Galloway, J., McHugh, N., McGrogan, A., Hackett, S., Brooke, M., Cavill, C., & Tillett, W. (2025). Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.02.020
Vancouver
Charlton RA, Gates E, Coates LC, Galloway J, McHugh N, McGrogan A, et al. Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.02.020
BibTeX
@article{Charlton2025,
author = {Charlton, Rachel A and Gates, Emer and Coates, Laura C and Galloway, James and McHugh, Neil and McGrogan, Anita and Hackett, Simon and Brooke, Melanie and Cavill, Charlotte and Tillett, William},
title = {Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.02.020}
}
EUVIMED